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Abstract
Genomewide association studies have become the primary tool for discovering the genetic basis of
complex human diseases. Such studies are susceptible to the confounding effects of population
stratification, in that the combination of allele-frequency heterogeneity with disease-risk
heterogeneity among different ancestral subpopulations can induce spurious associations between
genetic variants and disease. This article provides a statistically rigorous and computationally
feasible solution to this challenging problem of unmeasured confounders. We show that the odds
ratio of disease with a genetic variant is identifiable if and only if the genotype is independent of
the unknown population substructure conditional on a set of observed ancestry-informative
markers in the disease-free population. Under this condition, the odds ratio of interest can be
estimated by fitting a semiparametric logistic regression model with an arbitrary function of a
propensity score relating the genotype probability to ancestry-informative markers. Approximating
the unknown function of the propensity score by B-splines, we derive a consistent and
asymptotically normal estimator for the odds ratio of interest with a consistent variance estimator.
Simulation studies demonstrate that the proposed inference procedures perform well in realistic
settings. An application to the well-known Wellcome Trust Case-Control Study is presented.
Supplemental materials are available online.
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1. INTRODUCTION
One and a half decades ago, Risch and Merikangas (1996) showed that genomewide
association (GWA) studies interrogating hundreds of thousands or more genetic variants
have far greater power than traditional linkage studies in detecting the genetic factors for
complex human diseases (e.g., cancer, diabetes, cardiovascular diseases, mental disorders).
The catalog of single nucleotide polymorphisms (SNPs) (International HapMap Consortium
2005) and the advances in genotyping technology have made GWA studies a reality. Indeed,
the number of these studies has grown exponentially in recent years, and their success in
identifying genetic basis of complex human diseases was declared “breakthrough of the
year” by the journal Science in 2007. Most GWA studies use a case-control design, which
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compares the allele frequencies between disease subjects (i.e., cases) and disease-free
subjects (i.e., controls). Because of the need to adjust for multiple testing, large samples are
required to attain sufficient power in detecting the modest genetic effects expected for
complex human diseases.
It is widely recognized that unobserved population substructure or stratification can generate
spurious associations, that is, associations between disease and genetic variants that are not
linked to any causative loci (Lander and Schork 1994). This problem of unmeasured
confounders arises when the population under study is composed of several latent ancestral
subpopulations that have different allele frequencies and also different risks of disease. The
effects of stratification increase with sample size, so that even subtle population substructure
can yield grossly inflated type I error for large GWA studies. Case-control studies are
particularly prone to population stratification, especially when cases and controls are
obtained from different sources. Indeed, the concern over population stratification led many
to advocate family-based studies, which are more costly and less powerful than case-control
studies.
Delvin and Roeder (1999) proposed a simple approach, known as “genomic control,” to
correcting for population stratification in case-control studies. In this approach, the chi-
squared statistics are calculated at a set of null markers across the genome, and their
empirical median is divided by the median of the chi-squared distribution to produce an
inflation factor, which is then used to adjust the test statistics at all candidate SNPs. This
adjustment is crude, especially when the degrees of stratification vary substantially among
the SNPs.
Pritchard et al. (2000) developed the so-called “structured association,” which assigns
subjects to discrete subpopulations (with possibly fractional memberships) based on a set of
unlinked genetic markers and tests for associations within sub-populations. This approach is
computationally intractable for large numbers of markers. It is difficult to correctly estimate
the population substructure or to correctly assign individuals to subpopulations, especially
when the population under study is a continuous mixture of ancestral subpopulations.
The prevailing approach to adjusting for population stratification is principal components
analysis, which infers continuous axes of genetic variation from genomic markers and
includes those axes as covariates in the association analysis (Chen et al. 2003; Zhang, Zhu,
and Zhao 2003; Price et al. 2006). It is unclear how many axes should be used or how their
effects on disease should be modeled. Price et al. (2006) suggested including the 10 axes
with the highest eigenvalues as covariates with linear effects, and their method,
EIGENSTRAT, has been used in virtually all recent GWA studies. The assumption of linear
effects is likely violated in practice. Zhang, Zhu, and Zhao (2003) and Chen et al. (2003)
modeled the effects semiparametrically thorough a kernel function, which can be
computationally unstable when the dimension is greater than two.
Epstein, Allen, and Satten (2007) calculated a stratification score, which is the individual’s
estimated odds of disease as a function of his or her ancestry-informative markers, and
tested for association within strata defined by the stratification score. The use of the
stratification score tends to attenuate the estimates of the genetic effects at candidate SNPs
and thus reduce statistical power, especially when the set of ancestry-informative markers is
large (Lee et al. 2008). Recently, Zhao, Rebbeck, and Mitra (2009) calculated a propensity
score (Rosenbaum and Rubin 1983) by regressing the genotype of each candidate SNP on
ancestry-informative markers, and used the resulting propensity score as a linear term in the
logistic regression model for the disease association; they did not theoretically justify their
method.
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This article provides a rigorous statistical treatment of the problem of population
stratification. We formulate the confounding due to population stratification through
appropriate statistical models, identify necessary and sufficient conditions for the use of
genomic markers to correct for this confounding, and develop inference procedures that
properly correct for the confounding. Our methods avoid the aforementioned limitations of
the existing methods. Indeed, our theory yields valuable insights into the behavior of the
existing methods. We demonstrate the advantages of the new methods through simulated
and real data.
2. THEORY AND METHODS
2.1 Statistical Framework
We consider case-control GWA studies. Let D indicate, by the values 1 versus 0, whether or
not the subject has the disease of interest, and let G denote the genotype at a candidate locus,
which is defined as simply the number of minor alleles. We are interested in making
inference about the effect of G on D in the presence of population stratification. We
represent the unknown population substructure by an unobserved, possibly vector-valued
variable U. We collect data on a set of potentially correlated genomic markers, denoted by
Z, which is informative about the latent population substructure U.
It is natural to assume the following odds model:
(1)
where β is a parametric function, and γ is a completely unknown function. (The usual
intercept term is absorbed in the arbitrary function γ.) Under the additive mode of
inheritance, β(g) = βg; under the dominant or recessive mode of inheritance, β (g) = β I(g ≥
1) or β I(g = 2); under the co-dominant mode of inheritance, β (g) = β1I(g = 1) + β2I(g = 2).
The additive mode of inheritance is used almost exclusively in practice.
Remark I—Because of the arbitrariness of the function γ, model (1) is semiparametric.
Indeed, model (1) is completely nonparametric under the null hypothesis that β (g) = 0. This
feature is important because proper control of type I error is a prominent task in GWA
studies.
Remark 2—Model (1) allows certain ancestry-informative markers to be associated with
disease (even after conditioning on the true ancestry) and includes the special case where
ancestry-informative markers are independent of disease conditional on the true ancestry
such that
We normally set γ (u, z) in (1) to γ (u) so as to estimate the marginal effect of G, although
the general formulation allows estimation of the effect of G conditional on some other SNPs.
2.2 Identifiability
It is well known that odds ratios are identifiable from case-control data (Prentice and Pyke
1979). In our setting, however the odds ratio parameter β might not be identifiable, because
U is never observed. To be able to estimate β, we require that Z be sufficiently informative
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about U such that β can be correctly identified by stratifying on Z instead of on U. In other
words, the following model must hold:
(2)
where ξ is some unknown function different from γ. Theorem 1 and Proposition 1 provide
necessary and sufficient conditions under which model (1) indeed implies model (2).
Theorem 1—A necessary and sufficient condition for model (2) to hold is that U is
independent of G conditional on Z in the control population, that is,
(3)
Proposition 1
a. Condition (3) is equivalent to that U is independent of G conditional on Z in the
case population, that is,
(4)
b. If β = 0, then both (3) and (4) are equivalent to that U and G are independent given
Z in the study sample, that is, Pr(U = u|G = g, Z = z) = Pr(U = u|Z = z).
Remark 3—The foregoing results imply that it is possible to correct for the confounding
effects of U if Z dissolves the link between U and G such that U is independent of G for
each stratum of Z in the control population (or, equivalently, in the case population). Note
that the conditional independence does not hold in the whole population or in the combined
sample of cases and controls if there is population stratification and β is nonzero.
Remark 4—Conditions (3) and (4) are reasonable in that they require the aspect of the
unknown population substructure U, which needs to be controlled for when estimating the
effect of G to be fully contained in the observed marker data Z. These conditions hold
trivially if U is completely determined by Z. They also hold even if U is not completely
determined by Z but the part of U not captured by Z is unrelated to G.
The proofs of Theorem 1 and Proposition 1 are given in the Appendix. Hereinafter, we
assume that condition (3) or, equivalently, (4) holds. Our goal is to make inference on β.
2.3 Inference Procedures
The observed data consist of (Di, Gi, Zi), i = 1, …, n, where n is the total number of study
subjects. Under model (2), the likelihood takes the form
In general, it is difficult to maximize this likelihood, because the function ξ (·) is unknown
and can be highly nonlinear. If Z is discrete with a small number of values, then ξ (Z) can be
easily parameterized. If Z is continuous but very low-dimensional, we may apply a
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nonparametric smoothing method. If Z is discrete with many values or continuous with
dimension higher than three, then it is desirable to find a low-dimensional representation of




for some function ξ.
The proof is given in the Appendix. This result shows that we can simply identify a low-
dimensional function ψ (Z) such that G and Z are independent given ψ (Z) in the control
population. Clearly, ψ (Z) can be chosen to be Pr(G = g|Z = z, D = 0), which is at most two-
dimensional. We refer to this function as the genotype-associated propensity score (GAPS)
because it pertains to the propensity of having genotype g for a subject with markers Z.
There is an important difference between GAPS and the traditional propensity score of
Rosenbaum and Rubin (1983). The latter is used to mitigate the nonrandomness of treatment
assignment such that within each score stratum, the treatment assignment is independent of
the potential outcome under the assumption of no unmeasured confounders. In contrast, our
propensity score is used to remove the confounding of latent population substructure such
that within each score stratum, the genotype of the candidate SNP is independent of the
unmeasured confounders U. Under the odds ratio model, our propensity scores are based on
the relationship between G and Z in the control population rather than in the entire
population.
We may determine Pr(G = g|Z = z, D = 0) by supervised learning methods, such as
discriminant analysis, classification trees, and support vector machines. It is computationally
simpler to adopt a parametric model. For example, we may assume the proportional odds
model acknowledging the ordinal nature of G. It is biologically more sensible and
numerically more stable to formulate the effects of Z on G at the nucleotide level. Let G(1)
(or G(2)) indicate, by the values 1 versus 0, whether the nucleotide inherited from the father
(or the mother) is the minor allele, such that G = G(1) + G(2). It is natural to specify the
following logistic model:
(5)
(We have expanded Z to include the unit component and absorbed the intercept term in η.)
We set ψ (Z) = ηTZ, which is only one-dimensional. Without loss of generality, we focus on
the additive mode of inheritance such that β (G) = β G. Then model (2) becomes
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The likelihood for η based on the observed data (Di, Gi, Zi), i = 1, …, n, is
The resulting maximum likelihood estimator is denoted by η̂. Given η̂, we estimate β by
maximizing the following pseudo-likelihood function:
Because ξ (·) is an unknown function, adopting a nonparametric approach is desirable. The
simplest approach is to stratify the subjects into K strata based on the (estimated) propensity
scores {η̂TZi; i = 1, …, n}. Then β can be estimated by the standard logistic regression of D
on G and (K – 1) dummy variables. The discontinuity of the stratification makes it difficult
to account for the variation in estimating η. (Unlike the traditional propensity score, our
propensity score is conditional on the disease status, so its influence function is not
orthogonal to that of β; thus the variation in estimating the propensity score cannot be
ignored.)
We propose to use B-splines to approximate ξ. Specifically, let B1(·), …, BKn (·) be the B-
spline basis functions of order m (m ≥ 3) with the interior knots being the k/(Kn – 2m) (k = 0,
1, …, Kn – 2m) quantiles of {η̂TZi; i = 1, …, n}. Then ξ (x) can be approximated by
, where θ1, …, θKn are unknown coefficients. We estimate β and θ ≡ (θ1, …,
θKn)
T by maximizing the following approximate log-likelihood function:
This maximization can be done using the standard Newton–Raphson algorithm. The
resulting estimators are denoted by β ̂ and θ ̂.
The asymptotic properties of β ̂ are stated in the following theorem. In this theorem and in its
proof, given in the Appendix, ζ0 denotes the true value of any parameter or function ζ.
Theorem 3—Assume that the following regularity conditions hold:
(C.1) If cTZ = 0 with probability 1 for some constant vector c, then c = 0. In addition,
 with positive probability.
(C.2) The support of Z is bounded, and  has a bounded continuous support.
(C.3) The function γ0(u, z) and the joint density of (U, Z) have bounded fourth
derivatives and are bounded away from 0 in the support of (U, Z).
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(C.4) The number of the B-spline basis functions Kn → ∞, , and
.
Then n1/2(β ̂ − β0) converges in distribution to a mean-0 normal random variable.
Remark 5—The first part of condition (C.1) is equivalent to the linear independence of Z,
and the second part ensures that G is not completely determined by . This condition is
required for the consistency of the parameter estimators. Conditions (C.2) and (C.3) impose
some smoothness on the distribution of (U, Z). Condition (C.4) is satisfied by any Kn = nν
with ν ∈ (1/14, 1/12).
Remark 6—The number of basis functions Kn plays the role of the smoothing parameter in
B-splines. The value of Kn should be large enough so that the B-spline basis is flexible, but
not too large, to avoid overfitting. We typically set Kn to be between 2 and 10. If the effects
of populations stratification are fully accounted for, then the genomic control λ (Delvin and
Roeder 1999), which is the ratio of the median of the observed chi-squared test statistics to
the theoretical median of the chi-squared distribution, will be equal to 1. Thus we may
choose a value of Kn such that the resulting λ is close to 1.
The proof of Theorem 3 is given in the Appendix. The main challenge is that the dimension
of the parameter vector θ increases with increasing sample size. In the proof, we show that
the asymptotic variance of β ̂ can be consistently estimated by treating model (6) as a
parametric model with parameters β, θ, and η. A sandwich variance estimator is used to
account for the variation due to the plug-in estimation of η.
It follows from Proposition 1(a) that the conclusion of Theorem 2 also holds if Pr(G = g|Z =
z, D = 1) = Pr(G = g|ψ(Z) = ψ(z), D = 1). Thus Theorem 3 continues to hold if we replace D
= 0 in model (5) by D = 1. We refer to our methods as GAPS(C) if η is estimated from the
control sample and GAPS(D) if η is estimated from the disease (i.e., case) sample.
Estimating η from the combined sample of cases and controls is generally invalid.
Although both are theoretically valid, GAPS(C) and GAPS(D) may yield different results in
actual data analysis. In our approach, the propensity scores are first calculated from the
control or case sample and then matched into the other sample. The scores calculated from
the sample with a finer latent substructure might not be well matched in the sample with a
coarser latent substructure, and the resulting GAPS method might not be fully effective. For
this reason, we suggest using both GAPS(C) and GAPS(D) in practice. If the latent
substructures are balanced between the case and control samples, then the two methods will
yield similar results; otherwise, the mismatch of the two samples may warrant further
investigation.
2.4 Dimension Reduction
GWA studies survey the entire genome with high-density genotyping platforms containing
approximately 1 million SNPs. It is customary to infer ancestry from the dense SNP data
themselves rather than collect additional data on ancestry informative markers. For such
high-dimensional markers, however, estimating ψ(Z) of Section 2.3 directly is a challenge.
We suggest reducing the dimension of Z before applying the methods described in Section
2.3. Particularly, we find a low-dimensional representation of Z by performing principal
components analysis on a distance matrix among study subjects.
Define the n × p matrix X, whose ith row is the 1 × p vector of genotypes for the ith subject.
We standardize each column of X to have mean 0 and variance 1. The resulting matrix is
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still denoted by X. We define an n × n distance matrix whose (i, j)th element is a distance
measure between the ith and jth subjects (i.e., the ith and jth rows of X). The choice of the
correlation of genotypes as the distance yields EIGENSTRAT, whereas setting the distance
to the square root of the maximum of the correlation of genotypes and 0 yields Laplacian
eigenmaps (Zhang, Niyogi, and McPeek 2009; Lee et al. 2010). The latter distance is less
sensitive to outliers (i.e., subjects with markedly different ancestry) than the former. We
perform an eigenvalue decomposition of the distance matrix. The first few principal
components (PCs) are the low-dimension representation of X and will replace Z in the
inference procedures of Section 2.3. According to the multidimensional scaling theory, the
space spanned by the first few PCs is the optimal low-dimensional embedding, which tends
to preserve the original pairwise distances.
Remark 7—By replacing the original set of markers Z with the PCs, we now require that
condition (3) or equivalent condition (4) hold, with Z being the PCs. Note that the original Z
might contain certain information that is not part of the PCs as long as that information is
not associated with U or G. Although a larger number of PCs yields a more accurate low-
dimensional representation, including a very large number of PCs in association analysis
may cause numerical instability. For most studies, population substructures are well
captured by the first few (e.g., 10) PCs.
2.5 Comparisons With Other Approaches
Our approach is in the same vein as EIGENSTRAT, the stratification score of Epstein et al.
(EAS), and the propensity score of Zhao et al. (ZRM), in that all four approaches adjust for
population stratification by including ancestry-related covariates in the logistic regression
model for the SNP–disease association. For EIGENSTRAT, the covariates are the top 10
PCs. For EAS, the covariate pertains to the probability of disease given ancestry-informative
markers. ZRM uses the propensity score based on the entire sample, whereas our approach
uses the propensity score based on the control sample or case sample, in this section we
examine the differences between our approach and EIGENSTRAT, EAS, and ZRM.
Both our approach and EIGENSTRAT use principal components analysis for dimension
reduction. In our approach, the ancestry-related covariate used in the SNP-disease
association model is a scalar function of the PCs, and its effect on the disease status is
modeled nonparametrically. In EIGENSTRAT, the PCs enter into the SNP–disease
association model as linear terms. As shown in the proof of Theorem 2,
so the effects of PCs on the odds ratio of disease can be highly nonlinear. For example, if U
is dichotomous with Pr(U = u|Z = z, D = 0) = euαz/(1 + eαz) and γ(u, z) = γu, then ξ(z) =
log{(1 + eγ+αz)/(1 + eαz)}. Thus, EIGENSTRAT can yield biased estimation of the SNP–
disease association, although it is optimal when the assumption of linear effects holds. If
there is only a single PC, then the kernel method of Chen et al. (2003) is essentially
equivalent to our spline method. If there are more than two PCs, then this kernel method is
unstable, whereas our method is unaffected, because the propensity score is one-
dimensional.
The stratification score of EAS is an estimate of ξ in model (2) with β = 0, and thus removes
the bias due to population stratification under β = 0. To effectively remove the bias, the
stratification score must be calculated correctly. EAS calculates the stratification score as a
linear combination of ancestry-informative markers, even though ξ may be a highly
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nonlinear function. Because the stratification score of EAS involves the disease status, the
variation due to estimation of the score may not be ignored in the association testing. When
β ≠ 0, the stratification score is not an appropriate estimate of ξ, so the resulting estimator of
β may be biased. Originally, EAS selected ancestry-informative markers via partial least
squares regression, which can result in substantial overfitting and loss of power when there
are a large number of markers (Lee et al. 2008). Recently, Sarasua et al. (2009) suggested
calculating the stratification score based on the top 10 PCs instead of on individual markers.
Both our approach and ZRM rely on propensity scores. However, our propensity scores are
first calculated from the control or case sample and then matched to the other sample,
whereas those of ZRM are calculated from the combined sample of cases and controls. As
shown in Proposition 1(b), the propensity scores based on the entire sample are
inappropriate when β ≠ 0, and thus ZRM does not yield consistent estimators of nonzero β.
Even under the null hypothesis that β = 0, ZRM still may produce biased estimation of β
because it enters the propensity score into the SNP–disease association model as a linear
term, which is likely a faulty functional form. ZRM does not account for variation due to
estimation of the propensity scores, and thus may underestimate the variance of the
estimated genetic effect. ZRM has some other limitations, including requiring an arbitrary
dichotomization of G and accommodating only low-dimensional markers.
3. SIMULATION STUDIES
We conducted a series of simulation studies to assess the Performance of the proposed
methods in realistic settings. We used a case-control design with 1000 cases and 1000
controls. We generated data for controls as follows. We first simulated 1 million markers in
the same manner as done by Price et al. (2006). We then calculated the PCs for these
markers and set Z = (1, Z1, …, Z10)T, where Z1, …, Z10 are the top PCs. Given Z, we
generated G from model (5) with . We generated data for cases
under model (1) with β(g) = βg and γ(u, z) = γu using acceptance–rejection sampling.
Specifically, we generated Z and G as before and generated U from the logistic probability
function
where ε is an independent normal variable with mean 0 and variance σ2. (Note that U ranges
between 0 and 1 and can be understood as an ancestry proportion, such as the fraction of
European ancestry. If σ2 = 0, then U is determined by Z without error; if σ2 ≠ 0, then U is
not fully captured by Z.) We accepted the observation (G, Z) if a uniform [0, 1] random
variable was less than M−1eβG+γU, where M is an upper bound for eβG+γU, γ = −1.2, and β =
−0.4, 0 or 0.4.
We used B-splines of order 3 on the 10 quantiles of the propensity scores. For comparisons,
we included the logistic regression of D on G and Z, as well as the logistic regression of D
on G and U. The former pertains to EIGENSTRAT with Z being the PCs, and the latter
pertains to the ideal situation of known population substructure. We also included EAS and
ZRM. Table 1 summarizes the results of the simulation studies for making inference on β.
For GAPS, the parameter estimator is virtually unbiased, the standard error estimator is
accurate, and the type I error is close to the nominal significance level. Indeed, GAPS does
nearly as well as the logistic regression with known substructure in terms of bias, standard
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error, type I error, and power. EIGENSTRAT, EAS and ZRM all yield biased parameter
estimation and inflated type I error. Because the biases are positive whether the true β is
positive or negative, these three methods are more powerful than GAPS under β = 0.4 and
less powerful than GAPS under β = −0.4.
We also assessed the performance of GAPS under misspecified models. For example, we
generated G from model (5) with , but ignored the
interaction in calculating the propensity scores. Under β = 0, the bias of β ̂ was approximately
0.004 with standard error 0.08, and the type I error was approximately 0.0008 at the 10−3
nominal significance level, whether σ2 = 0 or 0.25. In addition, when the propensity scores
were generated from the proportional odds model but estimated under model (5), the
simulation results remained virtually the same.
Finally, we considered the simulation setting of Price et al. (2006), for which
EIGENSTRAT is optimal. We found that GAPS had accurate control of the type I error and
was nearly as powerful as EIGENSTRAT. For discrete subpopulations with moderate
ancestry differences between cases and controls, the power to detect the causal SNPs was
approximately 0.460 for GAPS and 0.483 for EIGENSTRAT; for admixed population with
ancestry differences between cases and controls based on ancestry risk r = 2, the power to
detect the causal SNPs was approximately 0.468 for GAPS and 0.485 for EIGENSTRAT.
4. REAL EXAMPLE
The Wellcome Trust Case Control Consortium (WTCCC) (2007) conducted a landmark
GWA study in the British population using the Affymetrix GeneChip 500K Mapping Array
Set. The study examined approximately 2000 individuals for each of seven major diseases—
bipolar disorder (BD), coronary artery disease (CAD), Crohn’s disease (CD), hypertension
(HT), rheumatoid arthritis (RA), type 1 diabetes (T1D), and type 2 diabetes (T2D)—and a
shared set of approximately 3000 controls. The seven conditions are all common familial
diseases of major public health significance. The control individuals came from two sources:
1500 individuals from the 1958 British Birth Cohort and 1500 individuals from blood
donors. Even after exclusion of individuals with evidence of recent non-European ancestry,
the British population is heterogeneous, having been shaped by several waves of
immigration from southern and northern Europe. The case and control samples might differ
in the distribution of ancestry, due either to bias in ascertaining controls or to
overrepresentation of sub-populations with higher disease risk in cases.
We wished to compare the effectiveness of the proposed and existing methods in correcting
for population stratification in the WTCCC data. After downloading the data from the
WTCCC Web site, we excluded the SNPs and subjects on the WTCCC’s exclusion lists. In
addition, we removed SNPs on the sex chromosomes, as well as any SNP with missing rate
> 5%, minor allele frequency < 1%, or Hardy–Weinberg p-value < 0.001. The resulting data
contain approximately 395,000 SNPs with slightly less than 5000 subjects for each case-
control comparison; see Table 2 for details. For principal components analysis, we removed
two small regions of known extensive local LD, namely the MHC region on chromosome 6
(25–35 Mb) and the chromosome 8 inversion region (7–13 Mb), excluded SNPs with minor
allele frequencies < 5%, and generated a pruned subset of SNPs with pairwise correlations
r2 < 0.25 through two iterations of the PLINK (Purcell et al. 2007) command “indep-
pairwise 200 100 0.25.” For each disease, the pruned subset contains approximately 81,000
SNPs. We performed principal components analysis on the pruned data sets by iteratively
deleting any SNPs that are strongly associated with the top 10 PCs (p-values < 10−8). We
used the top 10 PCs for all methods. Nonparametric estimation showed evidence of
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nonlinear effects of the PCs on the odds ratios of disease. For GAPS, we used B-splines of
order 3 on the 10 quantiles of the propensity scores.
Figure 1 provides quantile–quantile plots for Crohn’s disease. Without adjustment of
population stratification, the observed test statistics are noticeably higher than the expected
values, even in the left tail, and λ is approximately 1.11. EIGENSTRAT, EAS, and ZRM
change the results only slightly, with values of λ of 1.08, 1.09, and 1.07, respectively. For
both GAPS(C) and GAPS(D), the observed statistics agree well with the expected values
except in the extreme right tail, which corresponds to significant association signals, and the
values of λ are approximately 1.01.
Figure 2 compares the unadjusted analysis, EIGENSTRAT, and GAPS(C) for Crohn’s
disease. The first two methods yield highly similar results, whereas GAPS(C) reduces the
number of significant SNPs considerably and yields quite different rankings of the top
SNPs. The numbers of SNPs reaching the Bonferroni threshold of genomewide significance
are 70, 72, 68, 70, 58, and 63 for the unadjusted analysis, EIGENSTRAT, EAS, ZRM,
GAPS(C), and GAPS(D), respectively. For the top 100SNPs picked by the unadjusted
analysis, the Pearson’s correlation coefficients of the unadjusted analysis with
EIGENSTRAT, EAS, ZRM, GAPS(C), and GAPS(D) are 0.967, 0.981, 0.985, 0.935, and
0.918, respectively, and the corresponding Spearman’s rank correlation coefficients are
0.966, 0.986, 0.968, 0.915, and 0.938.
The results for the other six diseases are similar to those for Crohn’s disease. As shown in
Table 2, the λ values of GAPS(C) and GAPS(D) are very close to 1, except for BD and RA.
For all seven diseases, the λ values produced by GAPS(C) and GAPS(D) are closer to 1 than
those of EIGENSTRAT, EAS, and ZRM, the only exception being GAPS(C) for BD. When
we increased the number of knots from 10 to 12 for BD, the λ values for GAPS(C) and
GAPS(D) became 1.015 and 0.993. Incidentally, replacing the standard PCs with those of
Laplacian eigenmaps did not produce markedly different results; the details are omitted.
5. DISCUSSION
We have developed a theoretically justifiable and computationally feasible approach to
correcting for population stratification in GWA studies. Our methods maintain proper
control of type I error and provide consistent estimators of odds ratios with proper variance
estimators. The computing time for GAPS is longer than that for EIGENSTRAT, but by less
than one-fold. The relevant software will be posted on our Web site soon.
In the WTCCC example, we used the top 10 PCs for all methods. This approach, originally
suggested by Price et al. (2006), seems to work well empirically in terms of controlling λ. It
is possible to pick the PCs based on the Tracy–Widom (1994) test; however, that strategy
tends to identify a very large number of PCs, causing numerical instability in downstream
association analysis. We can determine which PCs to use by a variable selection procedure,
at the cost of additional computation time.
The estimation of the odds ratio of disease with a candidate SNP requires that condition (3)
or, equivalently, condition (4) holds. The validity of this condition, which is required not
only by our methods but also by all others, is not directly testable. Violation of this
assumption would be a potential source of the deviation of the observed test statistics from
the theoretical values in the quantile-quantile plot. In the Supplemental Materials, we
describe a method for conducting sensitivity analysis.
The only other possible reason for our methods to lose control of type I error would be
miscalculation of the propensity scores. To reduce the computational burden, we adopt a
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parametric approach to calculating the propensity scores. Our experience shows that GAPS
is insensitive to this modeling assumption. In our simulation studies, GAPS continued to
have correct type I error under various misspecified models for propensity scores. In the
analysis of the WTCCC data, the results were virtually unchanged when we replaced model
(5) by the proportional odds model. The robustness of GAPS to the model misspecification
for the propensity score is attributable to the fact that the effect of the propensity score on
the risk of disease is modeled nonparametrically. It is possible to avoid parametric modeling
as well as dimension reduction by relating the genotype of a candidate SNP directly to
genomic markers through a supervised learning technique (e.g., random forest, support
vector machine). Then the selected markers will be specific and predictive for that particular
SNP. It would be computationally intensive to do this for every candidate SNP in a GWA
study. One compromise might be to use parametric modeling for the initial screening and
then apply supervised learning to a small set of top SNPs.
In some studies, population stratification is due to cryptic relatedness or family structure.
The identifiability conditions presented in Section 2.2 still apply to such situations, because
eqs. (1)–(4) pertain to the marginal distribution of (D, G, U, Z). The proposed estimator of β
continues to be valid, but the variance estimation should account for the within-cluster
dependence through the generalized estimating equation approach.
We have focused on case-control studies. However, our theoretical development does not
rely on the case-control design, so our methods can be readily applied to cross-sectional
studies with binary traits. Similar methods can be developed for continuous traits in cross-
sectional studies and potentially censored age-at-onset data from cohort studies.
Furthermore, it is possible to expand our methods to make likelihood-based inference on
haplotype–disease associations along the lines of Lin and Zeng (2006).
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APPENDIX: PROOFS OF THEORETICAL RESULTS
Proof of Theorem 1
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where π0= Pr(D = 0) and π1= 1 − π0. Thus,
As a result,
Because γ is arbitrary, we conclude that
if and only if pr(U = u|G = g, Z = z, D = 0) does not depend on g. The theorem is proved.
Proof of Proposition 1
a. It follows from (A.1) that
(A.
2)
If U and G are independent conditional on Z in the control population, then Pr(U =
u, G = g|Z = z, D = 0) can be factorized into a product of two functions, one
involving (u, z) and one involving (g, z). Thus, the right side of (A.2) is also a
product of a function of (u, z) and a function of (g, z), which implies that U and G
are independent conditional on Z in the case population. The other direction can be
argued in a similar manner.
b. Clearly,
where p0 is the sample proportion of controls, and p1 = 1 − p0. It follows from (A.
1) that
If β(g) = 0, then Pr(U = u, G = g|Z = z) = Pr(U = u, G = g, Z = z|D = 0)ζ (u, z) for
some function ζ (u, z). Using the arguments of the previous paragraph, we obtain
the equivalence between the two conditional independence conditions. Note that
the equivalence does not hold if β(g) ≠ 0 and γ (u, z) depends on u.
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Proof of Theorem 2
Note that
Under model (1) and condition (3),
By the assumption of the theorem, Pr(G = g|Z = z, D = 0) = Pr(G = g|ψ (Z) = x, D = 0) for z
satisfying ψ (z) = x. Thus,
where
The conclusion holds.
Proof of Theorem 3
The proof of this theorem pertains to three major results: consistency, asymptotic normality,
and variance estimation.
Consistency
Let  and  denote the empirical and true probability measures, respectively. By the
classical likelihood theory for parametric models (e.g., Lehmann and Casella 1998, chap. 6),
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and a⊗2 = aaT for any column vector a. It follows from the proof of Theorem 2 and
condition (C.3) that ξ0(·) has a bounded fourth derivative. By theorem 6.25 of Schumaker
(2007), we can find a B-spline approximation to ξ0(x), denoted by , such
that  and , where  denotes the real line and
||f||W1,∞( ) = ||f||L∞( ) + ||f′||L∞( ) for any differentiable function f with derivative f′.
Define l(β, ξ; η) = D{βG + ξ(ηTZ)} − log{1 + eβG+ ξ(ηTz)}. Also, write .
Because l(β, ξ; η ̂) is maximized at (β ̂, ξ ̂), we have l(β ̂, ξ ̂; η ̂) ≥ l(β0, ξ̃; η ̂). Let





uniformly in G and Z, where . Thus, (A.4) yields
(A.
5)
By lemma 2.6.15 of van der Vaart and Wellner (1996), the function
belongs to a bounded Vapnik–Červonenkis class with index (Kn + 3) and has a bounded
covering function. Thus, the left side of (A.4) can be further bounded by Op(Knn−1/2). The
second-order Taylor expansion of the right side of (A.5) at (β0, ξ0) yields
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By similar arguments, there exists some positive constant c0 such that
It then follows from (A.5) and condition (C.1) that
where  denotes the support of . Because  for some




Condition (C.4) implies that  for sufficiently large n. It then
follows from (A.6) that
Thus,
which implies that
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By the choice of Kn in condition (C.4), we obtain |β ̂ − β0| → 0 and ||ξ ̂ − ξ0||W1,∞( ) → 0 in
probability. This proves the consistency.
To determine the convergence rate, we reexamine the inequality given in (A.4) by setting εn
to 1. Because ξ ̂ converges to ξ0 in W1,∞-norm, the left side of (A.4) is op(n−1/2), whereas the
right side is bounded from below by  for some positive
constant c2. Thus,
Asymptotic normality
We first derive the least favorable direction for β0; that is, we obtain a function h0(·) such
that
where lβ is the score for β0, lξ[h0] is the score function for ξ0 along the submodel ξ0 + εh0,
and  is the dual operator of lξ. By the semi-parametric efficiency theory (Bickel et al.
1993),
where . Clearly, h0(·) has a bounded fourth derivative.
We approximate h0 by the B-spline sequence h̃ and show that  and
. Because β ̂ solves the equation
we obtain lβ (β ̂, ξ ̂; η ̂) + lξ(β ̂, ξ ̂; η ̂) [h̃] = 0. Thus,
(A.
7)
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Because ξ ̂ and h̃ have bounded first derivatives and lβ and lξ are differentiable, the Donsker
theorem (van der Vaart and Wellner 1996, thm. 2.5.2) implies that the left side of (A.7) is
equal to
Given the consistency of (β ̂, ξ ̂, η ̂), the Taylor expansion of the right side of (A.7) yields
(A.
8)
where lββ (β, ξ; η) denotes the second derivative of l(β, ξ; η) with respect to β, lβξ (β, ξ; η)[h]
denotes the further derivative of lξ(β, ξ; η) [h] with respect to β, and lξξ (β, ξ, η)[h, h̃] denotes
the further derivative of lξ [h] along the submodel ξ + εh ̃.
The choice of h0 implies that the second term of (A.8) is 0. The convergence rate of (β ̂, ξ ̂),
together with condition (C.4), implies that the last term of (A.8) is op(n−1/2). Thus,
(A.
9)
We claim that that {lββ (β0, ξ0; η0) + lξβ(β0, ξ0, η0)[h0]} is nonzero. If this claim does not
hold, then lβ (β0, ξ0; η0) + lξ(β0, ξ0; η0)[h0] has zero variance and thus must be equal to 0
with probability 1. That is,  or  with probability 1, which
contradicts condition (C.1). The asymptotic normality of β ̂ then follows from (A.9) and (A.
3).
Variance estimation
From the proof of asymptotic normality, the influence function for β ̂ is
If we can find a consistent estimator of h0 in the L2(P) space, denoted by ĥ, then a consistent
estimator of the limiting variance of n1/2(β ̂ − β0) is
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To find a consistent estimator for h0, we solve the following equation:
(A.
11)
where the parameters (β, ξ, η) are evaluated at (β ̂, ξ ̂, η̂), and h is on the tangent space of the
sieve space, that is, . As a linear operator, the left side of (A.11)
converges to  with the parameters taking the true values. Because the information
operator  is invertible, so is . In addition, the inverse of the latter
converges to the inverse of the former. If then follows from the continuity of linear operators
that the solution to (A.11), denoted by ĥ, converges to h0.
Note that eq. (A.11) is essentially a system of linear equations. Algebraically, the calculation
of (A.10) is equivalent to the variance estimation by treating model (6) as a parametric
model with parameters β, θ, and η. Thus, the limiting covariance matrix of n1/2(β ̂ − β0, (θ ̂ −
θ0)T)T can be consistently estimated by the sandwich estimator H−1VH−1, where
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Quantile–quantile plots for analysis of the WTCCC data on Crohn’s disease with or without
correction for population stratification. The straight line pertains to the null distribution.
Lin and Zeng Page 21














The p-values (< 10−2) for the analysis of the WTCCC data on Crohn’s disease with or
without correcting for population stratification. The dashed line pertains to the Bonferroni
threshold for genomewide significance.
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